Q-omics provides the consensus-scored THOC7-AS1 profile across patient tissues and cancer cell-line models. THOC7-AS1 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, THOC7-AS1 is differentially expressed in 9, with the highest sampling consensus in COAD. Additionally, THOC7-AS1 RNA expression shows 13,199 significant gene co-expression associations, with the highest sampling consensus in LAML. Together, these results highlight KICH, COAD, and LAML as cancer lineages where THOC7-AS1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for THOC7-AS1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes THOC7-AS1 survival associations across molecular data types. THOC7-AS1 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible THOC7-AS1 RNA expression–survival associations across cancer types. High THOC7-AS1 expression shows unfavorable associations in KICH, ACC and PAAD, but favorable associations in OV, UCEC and READ. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for THOC7-AS1 RNA expression.
This table summarizes THOC7-AS1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for THOC7-AS1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. THOC7-AS1 shows lower tumor expression in LUAD and STAD and higher tumor expression in COAD, LIHC, PRAD and CHOL. The COAD box plot shows higher THOC7-AS1 RNA expression in tumor versus normal tissue (log2 FC = +0.184, t-test p = .002).
This table shows molecular features associated with THOC7-AS1 in patient tissues and cancer cell lines. In patient samples, THOC7-AS1 shows the broadest associations at the RNA and protein expression levels, with LAML recurring as the lineage with the largest associated feature set.
